AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY
Provided are methods of treating or ameliorating the symptoms of limb girdle muscular dystrophy by administration of therapeutically effective doses of adeno-associated (AAV) or recombinant adeno-associated viruses (rAAV) containing a transgene encoding AU- rich element-binding factor 1 (AUF1) effec...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DANOS, Olivier KARUMUTHIL-MELETHIL, Subha QIAO, Chunping FOLTZ, Steven ABBADI, Dounia ELLIOTT, Kirk LIU, Ye SCHNEIDER, Robert |
| description | Provided are methods of treating or ameliorating the symptoms of limb girdle muscular dystrophy by administration of therapeutically effective doses of adeno-associated (AAV) or recombinant adeno-associated viruses (rAAV) containing a transgene encoding AU- rich element-binding factor 1 (AUF1) effective to treat the limb girdle muscular dystrophy. Also provided are AAV and rAAV vectors encoding AUF1 proteins.
L'invention concerne des méthodes de traitement ou d'amélioration des symptômes de la dystrophie musculaire des ceintures par administration de doses thérapeutiquement efficaces de virus adéno-associés (AAV) ou de virus adéno-associés recombinants (rAAV) contenant un transgène codant pour le facteur 1 de liaison à un élément riche en AU (AUF1) efficace pour traiter la dystrophie musculaire des ceintures. L'invention concerne également des vecteurs AAV et rAAV codant pour des protéines AUF1. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024020574A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024020574A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024020574A23</originalsourceid><addsrcrecordid>eNrjZDBxDHUzVHB39XNVCPFwDXIMiFRw8w9S8PH0dVJw9wxy8XFV8A0Ndg71cQxScIkMDgnyD_CI5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJgZGBqbmJo5GxsSpAgBNSygu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY</title><source>esp@cenet</source><creator>DANOS, Olivier ; KARUMUTHIL-MELETHIL, Subha ; QIAO, Chunping ; FOLTZ, Steven ; ABBADI, Dounia ; ELLIOTT, Kirk ; LIU, Ye ; SCHNEIDER, Robert</creator><creatorcontrib>DANOS, Olivier ; KARUMUTHIL-MELETHIL, Subha ; QIAO, Chunping ; FOLTZ, Steven ; ABBADI, Dounia ; ELLIOTT, Kirk ; LIU, Ye ; SCHNEIDER, Robert</creatorcontrib><description>Provided are methods of treating or ameliorating the symptoms of limb girdle muscular dystrophy by administration of therapeutically effective doses of adeno-associated (AAV) or recombinant adeno-associated viruses (rAAV) containing a transgene encoding AU- rich element-binding factor 1 (AUF1) effective to treat the limb girdle muscular dystrophy. Also provided are AAV and rAAV vectors encoding AUF1 proteins.
L'invention concerne des méthodes de traitement ou d'amélioration des symptômes de la dystrophie musculaire des ceintures par administration de doses thérapeutiquement efficaces de virus adéno-associés (AAV) ou de virus adéno-associés recombinants (rAAV) contenant un transgène codant pour le facteur 1 de liaison à un élément riche en AU (AUF1) efficace pour traiter la dystrophie musculaire des ceintures. L'invention concerne également des vecteurs AAV et rAAV codant pour des protéines AUF1.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240125&DB=EPODOC&CC=WO&NR=2024020574A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240125&DB=EPODOC&CC=WO&NR=2024020574A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DANOS, Olivier</creatorcontrib><creatorcontrib>KARUMUTHIL-MELETHIL, Subha</creatorcontrib><creatorcontrib>QIAO, Chunping</creatorcontrib><creatorcontrib>FOLTZ, Steven</creatorcontrib><creatorcontrib>ABBADI, Dounia</creatorcontrib><creatorcontrib>ELLIOTT, Kirk</creatorcontrib><creatorcontrib>LIU, Ye</creatorcontrib><creatorcontrib>SCHNEIDER, Robert</creatorcontrib><title>AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY</title><description>Provided are methods of treating or ameliorating the symptoms of limb girdle muscular dystrophy by administration of therapeutically effective doses of adeno-associated (AAV) or recombinant adeno-associated viruses (rAAV) containing a transgene encoding AU- rich element-binding factor 1 (AUF1) effective to treat the limb girdle muscular dystrophy. Also provided are AAV and rAAV vectors encoding AUF1 proteins.
L'invention concerne des méthodes de traitement ou d'amélioration des symptômes de la dystrophie musculaire des ceintures par administration de doses thérapeutiquement efficaces de virus adéno-associés (AAV) ou de virus adéno-associés recombinants (rAAV) contenant un transgène codant pour le facteur 1 de liaison à un élément riche en AU (AUF1) efficace pour traiter la dystrophie musculaire des ceintures. L'invention concerne également des vecteurs AAV et rAAV codant pour des protéines AUF1.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBxDHUzVHB39XNVCPFwDXIMiFRw8w9S8PH0dVJw9wxy8XFV8A0Ndg71cQxScIkMDgnyD_CI5GFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGJgZGBqbmJo5GxsSpAgBNSygu</recordid><startdate>20240125</startdate><enddate>20240125</enddate><creator>DANOS, Olivier</creator><creator>KARUMUTHIL-MELETHIL, Subha</creator><creator>QIAO, Chunping</creator><creator>FOLTZ, Steven</creator><creator>ABBADI, Dounia</creator><creator>ELLIOTT, Kirk</creator><creator>LIU, Ye</creator><creator>SCHNEIDER, Robert</creator><scope>EVB</scope></search><sort><creationdate>20240125</creationdate><title>AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY</title><author>DANOS, Olivier ; KARUMUTHIL-MELETHIL, Subha ; QIAO, Chunping ; FOLTZ, Steven ; ABBADI, Dounia ; ELLIOTT, Kirk ; LIU, Ye ; SCHNEIDER, Robert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024020574A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>DANOS, Olivier</creatorcontrib><creatorcontrib>KARUMUTHIL-MELETHIL, Subha</creatorcontrib><creatorcontrib>QIAO, Chunping</creatorcontrib><creatorcontrib>FOLTZ, Steven</creatorcontrib><creatorcontrib>ABBADI, Dounia</creatorcontrib><creatorcontrib>ELLIOTT, Kirk</creatorcontrib><creatorcontrib>LIU, Ye</creatorcontrib><creatorcontrib>SCHNEIDER, Robert</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DANOS, Olivier</au><au>KARUMUTHIL-MELETHIL, Subha</au><au>QIAO, Chunping</au><au>FOLTZ, Steven</au><au>ABBADI, Dounia</au><au>ELLIOTT, Kirk</au><au>LIU, Ye</au><au>SCHNEIDER, Robert</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY</title><date>2024-01-25</date><risdate>2024</risdate><abstract>Provided are methods of treating or ameliorating the symptoms of limb girdle muscular dystrophy by administration of therapeutically effective doses of adeno-associated (AAV) or recombinant adeno-associated viruses (rAAV) containing a transgene encoding AU- rich element-binding factor 1 (AUF1) effective to treat the limb girdle muscular dystrophy. Also provided are AAV and rAAV vectors encoding AUF1 proteins.
L'invention concerne des méthodes de traitement ou d'amélioration des symptômes de la dystrophie musculaire des ceintures par administration de doses thérapeutiquement efficaces de virus adéno-associés (AAV) ou de virus adéno-associés recombinants (rAAV) contenant un transgène codant pour le facteur 1 de liaison à un élément riche en AU (AUF1) efficace pour traiter la dystrophie musculaire des ceintures. L'invention concerne également des vecteurs AAV et rAAV codant pour des protéines AUF1.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2024020574A2 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | AUF1 GENE THERAPY FOR LIMB GIRDLE MUSCULAR DYSTROPHY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T10%3A07%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DANOS,%20Olivier&rft.date=2024-01-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024020574A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |